A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma. 1990

I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
Department of Medicine, Kochi Medical School, Japan.

A new human lymphoma cell line, designated DL-40, was established from the peripheral blood of a 64-year-old woman with leukemic conversion of aggressive large cell lymphoma. The cell line grew in suspension with or without forming clumps of cells and exhibited large, round, or multiple nuclei in the relatively abundant cytoplasm that was positive for acid phosphatase. The cells expressed a Ki-1 antigen (CD30), E+, CD2+, CD4+, CD45+, Ia+ phenotype and had rearranged T-cell receptor beta chain but were negative for CD15, HTLV-I, and Epstein-Barr virus nuclear antigen. Chromosome analysis of this cell line showed a human female karyotype with complex hyperdiploid abnormalities. DL-40 cells produced tumors histologically similar to the original lymphoma when transplanted into nude mice and immunosuppressed hamsters. The DL-40 cell line could provide a useful tool for the understanding of biology of the Ki-1-positive non-Hodgkin's lymphoma.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D000945 Antigens, Differentiation, T-Lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens, Differentiation, T-Cell,Differentiation Antigens, T-Cell,L3T4 Antigens,Leu Antigens, T-Lymphocyte,T-Cell Differentiation Antigens,T-Lymphocyte Differentiation Antigens,T6 Antigens,Antigens, Differentiation, T Lymphocyte,Differentiation Antigens, T Lymphocyte,Antigens, L3T4,Antigens, T-Cell Differentiation,Antigens, T-Lymphocyte Differentiation,Antigens, T-Lymphocyte Leu,Antigens, T6,Differentiation Antigens, T Cell,Differentiation Antigens, T-Lymphocyte,Leu Antigens, T Lymphocyte,T Cell Differentiation Antigens,T Lymphocyte Differentiation Antigens,T-Lymphocyte Leu Antigens
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
July 1994, Leukemia,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
November 1988, Japanese journal of cancer research : Gann,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
December 2001, Journal of the American Academy of Dermatology,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
October 2010, Cirugia espanola,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
May 2005, The British journal of dermatology,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
January 1995, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
November 1992, Cancer,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
January 1993, Intervirology,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
January 1996, Annales de medecine interne,
I Kubonishi, and H Sonobe, and T Miyagi, and Y Iwahara, and J H Ohyashiki, and K Ohyashiki, and K Toyama, and Y Ohtsuki, and I Miyoshi
December 1994, Fukuoka igaku zasshi = Hukuoka acta medica,
Copied contents to your clipboard!